Key Takeaways
- ZEISS Medical Technology partners with Envision Health Technologies to utilize VR technology for glaucoma care.
- The collaboration aims to enhance access to glaucoma screenings and improve workflow flexibility.
- Both companies seek to develop patient-centered, clinically relevant technologies for modern eye care.
New Collaboration to Transform Glaucoma Care
ZEISS Medical Technology has entered into a strategic partnership with Envision Health Technologies, a digital eye health company created by glaucoma expert Dr Lama A. Al-Aswad. This collaboration focuses on advancing glaucoma care through gamified virtual reality (VR) technology. According to a ZEISS media release, the joint effort seeks to establish scientific and clinical credibility in VR-based visual function testing, drawing on ZEISS’ longstanding expertise in perimetry.
The partnership emerges as the demand for wider access to glaucoma screenings increases, highlighting the need for more adaptable workflow solutions. There’s growing industry interest in portable, software-driven methods for visual function testing, which this collaboration aims to address.
Anuj Kalra, head of Chronic Disease Management at ZEISS Medical Technology, emphasized the evolving landscape of glaucoma care, stating that clinicians are seeking solutions that enhance patient accessibility and experience without sacrificing clinical confidence. He noted that this collaboration aligns with ZEISS’ commitment to advancing practical innovations that can broaden access to visual function testing across various healthcare settings.
Dr Al-Aswad, founder and CEO of Envision Health Technologies, echoed this sentiment, asserting that the future of visual function testing should prioritize accessibility and patient-centeredness while maintaining clinical rigor. He believes that working with ZEISS allows for the integration of innovative software with decades of trusted market leadership in perimetry, leading to practical solutions for glaucoma care.
Dr Al-Aswad founded Envision Health Technologies with the mission of improving outcomes for vision-threatening diseases, developing advanced, data-driven solutions to transform the delivery, measurement, and scaling of vision care. This collaboration represents a significant step forward in modernizing glaucoma care, aiming to provide patients and clinicians with effective, accessible tools for managing eye health.
The content above is a summary. For more details, see the source article.
